Apple Inc. (AAPL)

Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.

Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.

Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.

Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.

Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.

Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.

Share reduction while VUZI is at 2.63%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.

Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.

Dividend growth of 9.72% while VUZI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.

Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.

Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.

Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.

Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.

Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.

10Y OCF/share CAGR above 1.5x VUZI's 78.65%. David Dodd would check if a superior product mix or cost edge drives this outperformance.

Positive OCF/share growth while VUZI is negative. John Neff might see a comparative advantage in operational cash viability.

Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.

Net income/share CAGR above 1.5x VUZI's 30.81% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.

Positive 5Y CAGR while VUZI is negative. John Neff might view this as a strong mid-term relative advantage.

Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.

Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.

5Y equity/share CAGR above 1.5x VUZI's 32.66%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.

3Y equity/share CAGR above 1.5x VUZI's 39.13%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.

Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.

Inventory is declining while VUZI stands at 17.95%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.

Positive asset growth while VUZI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.

Positive BV/share change while VUZI is negative. John Neff sees a clear edge over a competitor losing equity.

We have some new debt while VUZI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.

R&D dropping or stable vs. VUZI's 63.93%. David Dodd sees near-term margin benefits if the product pipeline is already strong.

We cut SG&A while VUZI invests at 17.70%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.